Clinical Trials
Learn More

Patient information on
AVAX's Phase III
Registration Study MVALDI

Clinical News

AVAX Technologies Inc. Announces the Appointment of Chief Executive Officer

AVAX Announces Settlement Agreement with Cancer Treatment Centers of America and Approves $45 Million Private Placement Financing

AVAX Technologies Announces Expansion of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax®)

© 2015 AVAX Technologies, Inc. | Terms
Site design: Schenkel/Stegman
Management Board of Directors Fact Sheet (pdf)
Product Pipeline & Overview Publications

Overview SEC Filings Information Request Press Releases
Home | Site Map | Contact Us